Business
Day One Biopharmaceuticals Inc (DAWN) Offers An Excellent Investment Opportunity At Current Levels
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) at last check was buoying at $14.96 on Thursday, March 21, with a rise of 1.98% from its closing price
